33 Results

People

  1. Moskowitz
    Moskowitz
  2. Zelenetz
    Zelenetz
  3. Horwitz
    Horwitz
  4. Noy
    Noy
  5. Palomba
    Palomba
  6. Hamlin
    Hamlin
  7. Kumar
    Kumar
  8. Intlekofer
    Intlekofer
  9. Caron
    Caron
  10. Vardhana
    Vardhana

Groups

  1. Center for Hematologic Malignancies (33)
  2. Department of Medicine (33)
  3. GSK Faculty (33)
  4. Hematologic Malignancies, Division of (33)
  5. Lymphoma (33)
  6. Human Oncology and Pathogenesis Program (31)
  7. Population Sciences Research Program (31)
  8. Hematologic Malignancies Research (27)
  9. Survivorship Research (25)
  10. Sloan Kettering Institute Postdocs (22)
  1. "Center for Hematologic Malignancies"
  2. "Department of Medicine"
  3. "GSK Faculty"
  4. "Alison Moskowitz"
  5. "Andrew Zelenetz"
Formats
  1. Meeting Abstract (27)
  2. Journal Article (5)
  3. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (33)
  2. Department of Medicine (33)
  3. GSK Faculty (33)
  4. Hematologic Malignancies, Division of (33)
  5. Lymphoma (33)
  6. Human Oncology and Pathogenesis Program (31)

More Groups

People
  1. Alison Moskowitz (33)
  2. Andrew Zelenetz (33)
  3. Ariela Noy (31)
  4. Steven Horwitz (31)
  5. Maria Palomba (30)
  6. Paul Hamlin (29)

More People

Years
  1. 2024 (1)
  2. 2023 (13)
  3. 2022 (3)
  4. 2021 (2)
  5. 2020 (4)
  6. 2019 (1)

More Years

Publications
  1. Blood (22)
  2. Hematological Oncology (3)
  3. Journal of Clinical Oncology (3)
  4. Blood Advances (2)
  5. Blood Cancer Journal (1)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (24)
  2. American Society of Clinical Oncology (3)
  3. Wiley Blackwell (3)
  4. John Wiley & Sons (1)
  5. Nature Publishing Group (1)
  6. Society of Nuclear Medicine (1)

Results (33)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gemcitabine plus pembrolizumab after checkpoint blockade failure as a strategy in multiply relapsed Hodgkin lymphoma
    Research Letter

    Stuver, R.; Noy, A.; Vardhana, S. A.; Zelenetz, A. D.; Moskowitz, A. J.
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Responses and outcomes after second-line therapy in transplant-eligible patients with DLBCL relapse over 1 year after first-line therapy
    Meeting Abstract

    Qualls, D. A.; Shah, G. L.; Shouval, R.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of early histological transformation on survival in patients with follicular lymphoma
    Meeting Abstract

    Luttwak, E.; Qiu, A.; Okwali, M.; Rivas-Delgado, A.; Isgor, I.; Boardman, A. P.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Infectious complications in patients with relapsed or refractory (R/R) Non-Hodgkin's lymphoma (NHL) treated with the anti-CD20xCD3 bispecific antibody (BsAb) mosunetuzumab
    Meeting Abstract

    Shahid, Z.; Okwali, M.; Joseph, A.; Seo, S. K.; Lue, J. K.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of limited stage high grade B-cell lymphoma with MYC/BCL2 and/or BCL6 rearrangements: A single center experience
    Meeting Abstract

    Lue, J. K.; Luttwak, E.; Caron, P.; Boardman, A. P.; David, K. A.; Rivas-Delgado, A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Brentuximab vedotin-based regimens for older patients with newly diagnosed classical Hodgkin lymphoma -Real world experience
    Meeting Abstract

    Luttwak, E.; Ganesan, N.; Boardman, A. P.; Caron, P.; David, K. A.; Rivas-Delgado, A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Ruxolitinib promotes clinical responses in large granular lymphocytic leukemia via suppression of JAK/STAT-dependent inflammatory cascades
    Meeting Abstract

    Moskowitz, A.; Rahman, J.; Ganesan, N.; Hannigan, K.; Ksanznak, K.; Bitton, H.; Lin, Y. H.; Davey, T.; Hancock, H.; Perez, L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Predicting toxicities in older adults with non-Hodgkin lymphoma (NHL) receiving systemic chemotherapy: A prospective geriatric assessment (GA) study
    Meeting Abstract

    Torka, P.; Drill, E.; Ganesan, N.; Oliveros, M.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Distinct patterns of CD4+and CD8+ T-cell clonal expansion enable broad clinical responses to pembrolizumab + GVD in patients with relapsed Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Rahman, J.; Ganesan, N.; Shah, G. L.; Noy, A.; Schoder, H.; Yahalom, J.; Kumar, A.; Falchi, L.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Real-life experience with lenalidomide plus anti-CD20 antibodies for the treatment of patients (pts) with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL)
    Meeting Abstract

    Cassanello, G.; Rivas-Delgado, A.; Luna De Abia, A.; Corona, M.; Luttwak, E.; Okwali, M.; Isgor, I.; Galera, P.; Boardman, A. P.; Caron, P.; more...
    Blood (2023)

    Fulltext@MSK | Save